316 related articles for article (PubMed ID: 32565912)
1. Orodispersible budesonide tablets for the treatment of eosinophilic esophagitis: a review of the latest evidence.
Miehlke S; Lucendo AJ; Straumann A; Jan Bredenoord A; Attwood S
Therap Adv Gastroenterol; 2020; 13():1756284820927282. PubMed ID: 32565912
[TBL] [Abstract][Full Text] [Related]
2. Evidence-based treatments for eosinophilic esophagitis: insights for the clinician.
Feo-Ortega S; Lucendo AJ
Therap Adv Gastroenterol; 2022; 15():17562848211068665. PubMed ID: 35069803
[TBL] [Abstract][Full Text] [Related]
3. Treatment of eosinophlic esophagitis with swallowed topical corticosteroids.
Nennstiel S; Schlag C
World J Gastroenterol; 2020 Sep; 26(36):5395-5407. PubMed ID: 33024392
[TBL] [Abstract][Full Text] [Related]
4. Swallowed topical corticosteroids for eosinophilic esophagitis: Utilization and real-world efficacy from the EoE CONNECT registry.
Laserna-Mendieta EJ; Navarro P; Casabona-Francés S; Savarino EV; Amorena E; Pérez-Martínez I; Guagnozzi D; Blas-Jhon L; Betoré E; Guardiola-Arévalo A; Pellegatta G; Krarup AL; Perello A; Barrio J; Gutiérrez-Junquera C; Teruel Sánchez-Vegazo C; Fernández-Fernández S; Naves JE; Oliva S; Rodríguez-Oballe JA; Carrión S; Espina S; Llorente Barrio M; Masiques-Mas ML; Dainese R; Feo-Ortega S; Martín-Dominguez V; Fernández-Pacheco J; Pérez-Fernández MT; Ghisa M; Maniero D; Nantes-Castillejo Ó; Nicolay-Maneru J; Suárez A; Maray I; Llerena-Castro R; Ortega-Larrodé A; Alcedo J; Granja Navacerrada A; Racca F; Santander C; Arias Á; Lucendo AJ;
United European Gastroenterol J; 2024 Jun; 12(5):585-595. PubMed ID: 38284792
[TBL] [Abstract][Full Text] [Related]
5. Novel corticosteroid formulations in the treatment of eosinophilic esophagitis: what is the evidence?
Walgraeve S; Vanuytsel T
Acta Gastroenterol Belg; 2023; 86(3):437-448. PubMed ID: 37814560
[TBL] [Abstract][Full Text] [Related]
6. Eosinophilic esophagitis--treatment of eosinophilic esophagitis with drugs: corticosteroids.
von Arnim U; Malfertheiner P
Dig Dis; 2014; 32(1-2):126-9. PubMed ID: 24603395
[TBL] [Abstract][Full Text] [Related]
7. Drug treatment strategies for eosinophilic esophagitis in adults.
Lucendo AJ
Expert Opin Pharmacother; 2022 May; 23(7):827-840. PubMed ID: 35379069
[TBL] [Abstract][Full Text] [Related]
8. Treatment of eosinophilic esophagitis in the pediatric patient: an evidence-based approach.
Munoz-Persy M; Lucendo AJ
Eur J Pediatr; 2018 May; 177(5):649-663. PubMed ID: 29549437
[TBL] [Abstract][Full Text] [Related]
9. Emerging therapies for eosinophilic esophagitis.
Greuter T; Hirano I; Dellon ES
J Allergy Clin Immunol; 2020 Jan; 145(1):38-45. PubMed ID: 31705907
[TBL] [Abstract][Full Text] [Related]
10. Update on Emerging Pharmacologic Therapies for Patients With Eosinophilic Esophagitis.
Syverson EP; Hait E
Gastroenterol Hepatol (N Y); 2022 Apr; 18(4):207-212. PubMed ID: 35505944
[TBL] [Abstract][Full Text] [Related]
11. Topical steroids in eosinophilic esophagitis: Systematic review and meta-analysis of placebo-controlled randomized clinical trials.
Murali AR; Gupta A; Attar BM; Ravi V; Koduru P
J Gastroenterol Hepatol; 2016 Jun; 31(6):1111-9. PubMed ID: 26699695
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of Budesonide Orodispersible Tablets as Induction Therapy for Eosinophilic Esophagitis in a Randomized Placebo-Controlled Trial.
Lucendo AJ; Miehlke S; Schlag C; Vieth M; von Arnim U; Molina-Infante J; Hartmann D; Bredenoord AJ; Ciriza de Los Rios C; Schubert S; Brückner S; Madisch A; Hayat J; Tack J; Attwood S; Mueller R; Greinwald R; Schoepfer A; Straumann A;
Gastroenterology; 2019 Jul; 157(1):74-86.e15. PubMed ID: 30922997
[TBL] [Abstract][Full Text] [Related]
13. Delayed hypersensitivity reaction to orodispersible budesonide in a case with eosinophilic esophagitis.
Andrist CM; Jörg L; Greuter T; Gschwend A; Straumann A; Helbling A
BMC Gastroenterol; 2020 Dec; 20(1):419. PubMed ID: 33308158
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of eosinophilic esophagitis - advancements and perspectives].
Miehlke S; von Arnim U; Schlag C; Labenz J; Madisch A
Z Gastroenterol; 2021 Aug; 59(8):869-878. PubMed ID: 34157757
[TBL] [Abstract][Full Text] [Related]
15. Recent insights on the use of topical steroids in eosinophilic esophagitis.
Reddy A; Ashat D; Murali AR
Expert Rev Gastroenterol Hepatol; 2020 Oct; 14(10):953-963. PubMed ID: 32567417
[TBL] [Abstract][Full Text] [Related]
16. Budesonide Orodispersible Tablets Maintain Remission in a Randomized, Placebo-Controlled Trial of Patients With Eosinophilic Esophagitis.
Straumann A; Lucendo AJ; Miehlke S; Vieth M; Schlag C; Biedermann L; Vaquero CS; Ciriza de Los Rios C; Schmoecker C; Madisch A; Hruz P; Hayat J; von Arnim U; Bredenoord AJ; Schubert S; Mueller R; Greinwald R; Schoepfer A; Attwood S;
Gastroenterology; 2020 Nov; 159(5):1672-1685.e5. PubMed ID: 32721437
[TBL] [Abstract][Full Text] [Related]
17. Histologic and Clinical Effects of Different Topical Corticosteroids for Eosinophilic Esophagitis: Lessons from an Updated Meta-Analysis of Placebo-Controlled Randomized Trials.
de Heer J; Miehlke S; Rösch T; Morgner A; Werner Y; Ehlken H; Becher H; Aigner A
Digestion; 2021; 102(3):377-385. PubMed ID: 32610332
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of eosinophilic esophagitis - advancements and perspectives].
Miehlke S; Arnim UV; Schlag C; Labenz J; Madisch A
Laryngorhinootologie; 2023 May; 102(5):339-348. PubMed ID: 37141876
[TBL] [Abstract][Full Text] [Related]
19. Eosinophilic Esophagitis: Impact of Latest Insights Into Pathophysiology on Therapeutic Strategies.
Schoepfer A; Safroneeva E; Straumann A
Dig Dis; 2016; 34(5):462-8. PubMed ID: 27333298
[TBL] [Abstract][Full Text] [Related]
20. Swallowed topical corticosteroids reduce the risk for long-lasting bolus impactions in eosinophilic esophagitis.
Kuchen T; Straumann A; Safroneeva E; Romero Y; Bussmann C; Vavricka S; Netzer P; Reinhard A; Portmann S; Schoepfer AM
Allergy; 2014 Sep; 69(9):1248-54. PubMed ID: 24894658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
